Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy
Abstract Background Despite recent advances in cancer immunotherapy, the efficacy of these therapies for the treatment of human prostate cancer patients is low due to the complex immune evasion mechanisms (IEMs) of prostate cancer and the lack of predictive biomarkers for patient responses. Methods...
Main Authors: | Mayassa J. Bou-Dargham, Linlin Sha, Qing-Xiang Amy Sang, Jinfeng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07058-y |
Similar Items
-
Immunotherapy and Immune Evasion in Prostate Cancer
by: Archana Thakur, et al.
Published: (2013-05-01) -
The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
by: Alberto Cruz-Bermúdez, et al.
Published: (2021-03-01) -
Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms
by: Jianyu Chen, et al.
Published: (2021-02-01) -
Immunotherapy Landscape in Prostate Cancer: Sucesses, Failures and Promises
by: Sabeeh‑ur‑Rehman Butt, et al.
Published: (2019-09-01) -
CD8+ T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
by: Aldo Pourchet, et al.
Published: (2016-03-01)